HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tool aims to protect cancer Survivors' hearts
Disease control CompletedThis study tested a computer tool that automatically shows a cancer survivor's heart health risks using their existing medical records. The goal was to see if this tool helped survivors and their cancer doctors have better conversations about heart health, leading to more referra…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy tested in kids battling tough cancers
Disease control CompletedThis early-stage study tested a new combination of two immunotherapy drugs (relatlimab and nivolumab) in children and young adults whose Hodgkin or non-Hodgkin lymphoma had come back or did not respond to standard treatments. The main goals were to find a safe dose and see if the…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug duo tested in fight against lymphoma
Disease control CompletedThis study tested the safety and initial effectiveness of a two-drug combination (favezelimab and pembrolizumab) for people with certain blood cancers, including Hodgkin lymphoma and non-Hodgkin lymphoma. It involved 137 participants to find a safe dose and see if the treatment c…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Wrist watch for the heart: study tests remote monitoring for cancer survivors
Knowledge-focused CompletedThis study tested if a commercially available wrist-worn fitness monitor (WHOOP®) could reliably measure heart rate and heart rate variability from home for survivors of Hodgkin lymphoma who had chest radiation. The goal was to see if the home monitor's readings matched those fro…
Matched conditions: HODGKIN DISEASE
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC